294 related articles for article (PubMed ID: 11970987)
1. CD28 costimulation induces delta opioid receptor expression during anti-CD3 activation of T cells.
Nguyen K; Miller BC
J Immunol; 2002 May; 168(9):4440-5. PubMed ID: 11970987
[TBL] [Abstract][Full Text] [Related]
2. Both CD28 ligands CD80 (B7-1) and CD86 (B7-2) activate phosphatidylinositol 3-kinase, and wortmannin reveals heterogeneity in the regulation of T cell IL-2 secretion.
Ueda Y; Levine BL; Huang ML; Freeman GJ; Nadler LM; June CH; Ward SG
Int Immunol; 1995 Jun; 7(6):957-66. PubMed ID: 7577804
[TBL] [Abstract][Full Text] [Related]
3. Synergy between CD28 and CD9 costimulation for naive T-cell activation.
Toyo-oka K; Tai XG; Yashiro Y; Ahn HJ; Abe R; Hamaoka T; Kobayashi M; Neben S; Fujiwara H
Immunol Lett; 1997 Jun; 58(1):19-23. PubMed ID: 9436464
[TBL] [Abstract][Full Text] [Related]
4. Phorbol esters modulate the coupling of the T cell costimulatory molecule CD28 to phosphatidylinositol 3-kinase.
Parry RV; Boulougouris G; Sansom DM; Ward SG
Biochem Soc Trans; 1997 May; 25(2):305S. PubMed ID: 9191349
[No Abstract] [Full Text] [Related]
5. The phosphatidylinositol phosphatase PTEN is under control of costimulation and regulates proliferation in human T cells.
Schmidt-Weber CB; Wohlfahrt JG; Akdis CA; Blaser K
Eur J Immunol; 2002 Apr; 32(4):1196-204. PubMed ID: 11932928
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of B7-1 and B7-2 on the costimulation of mouse nonspecific cytotoxic T lymphocyte development in response to anti-CD3 antibody.
Makrigiannis AP; Musgrave BL; Hoskin DW
J Leukoc Biol; 1999 Nov; 66(5):792-802. PubMed ID: 10577511
[TBL] [Abstract][Full Text] [Related]
7. Disparate effects of phorbol esters, CD3 and the costimulatory receptors CD2 and CD28 on RANTES secretion by human T lymphocytes.
Sotsios Y; Blair PJ; Westwick J; Ward SG
Immunology; 2000 Sep; 101(1):30-7. PubMed ID: 11012750
[TBL] [Abstract][Full Text] [Related]
8. LFA-1-mediated costimulation of CD8+ T cell proliferation requires phosphatidylinositol 3-kinase activity.
Ni HT; Deeths MJ; Mescher MF
J Immunol; 2001 Jun; 166(11):6523-9. PubMed ID: 11359803
[TBL] [Abstract][Full Text] [Related]
9. Tumor-specific T cell activation by recombinant immunoreceptors: CD3 zeta signaling and CD28 costimulation are simultaneously required for efficient IL-2 secretion and can be integrated into one combined CD28/CD3 zeta signaling receptor molecule.
Hombach A; Wieczarkowiecz A; Marquardt T; Heuser C; Usai L; Pohl C; Seliger B; Abken H
J Immunol; 2001 Dec; 167(11):6123-31. PubMed ID: 11714771
[TBL] [Abstract][Full Text] [Related]
10. Phorbol ester treatment inhibits phosphatidylinositol 3-kinase activation by, and association with, CD28, a T-lymphocyte surface receptor.
Hutchcroft JE; Franklin DP; Tsai B; Harrison-Findik D; Varticovski L; Bierer BE
Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8808-12. PubMed ID: 7568022
[TBL] [Abstract][Full Text] [Related]
11. Gr-1+ myeloid cells derived from tumor-bearing mice inhibit primary T cell activation induced through CD3/CD28 costimulation.
Kusmartsev SA; Li Y; Chen SH
J Immunol; 2000 Jul; 165(2):779-85. PubMed ID: 10878351
[TBL] [Abstract][Full Text] [Related]
12. Engagement of CD28 modulates CXC chemokine receptor 4 surface expression in both resting and CD3-stimulated CD4+ T cells.
Secchiero P; Zella D; Curreli S; Mirandola P; Capitani S; Gallo RC; Zauli G
J Immunol; 2000 Apr; 164(8):4018-24. PubMed ID: 10754293
[TBL] [Abstract][Full Text] [Related]
13. A short CD3/CD28 costimulation combined with IL-21 enhance the generation of human memory stem T cells for adoptive immunotherapy.
Alvarez-Fernández C; Escribà-Garcia L; Vidal S; Sierra J; Briones J
J Transl Med; 2016 Jul; 14(1):214. PubMed ID: 27435312
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous cross-linking of CD6 and CD28 induces cell proliferation in resting T cells.
Osorio LM; Rottenberg M; Jondal M; Chow SC
Immunology; 1998 Mar; 93(3):358-65. PubMed ID: 9640246
[TBL] [Abstract][Full Text] [Related]
15. CD28 co-stimulation stabilizes the expression of the CD40 ligand on T cells.
Johnson-Léger C; Christensen J; Klaus GG
Int Immunol; 1998 Aug; 10(8):1083-91. PubMed ID: 9723694
[TBL] [Abstract][Full Text] [Related]
16. Phosphatidylinositol 3-kinase inhibitors prevent mouse cytotoxic T-cell development in vitro.
Phu T; Haeryfar SM; Musgrave BL; Hoskin DW
J Leukoc Biol; 2001 May; 69(5):803-14. PubMed ID: 11358990
[TBL] [Abstract][Full Text] [Related]
17. CD28 costimulation mediates down-regulation of p27kip1 and cell cycle progression by activation of the PI3K/PKB signaling pathway in primary human T cells.
Appleman LJ; van Puijenbroek AA; Shu KM; Nadler LM; Boussiotis VA
J Immunol; 2002 Mar; 168(6):2729-36. PubMed ID: 11884439
[TBL] [Abstract][Full Text] [Related]
18. Costimulation of T cell activation by integrin-associated protein (CD47) is an adhesion-dependent, CD28-independent signaling pathway.
Reinhold MI; Lindberg FP; Kersh GJ; Allen PM; Brown EJ
J Exp Med; 1997 Jan; 185(1):1-11. PubMed ID: 8996237
[TBL] [Abstract][Full Text] [Related]
19. 4-1BB is superior to CD28 costimulation for generating CD8+ cytotoxic lymphocytes for adoptive immunotherapy.
Zhang H; Snyder KM; Suhoski MM; Maus MV; Kapoor V; June CH; Mackall CL
J Immunol; 2007 Oct; 179(7):4910-8. PubMed ID: 17878391
[TBL] [Abstract][Full Text] [Related]
20. 4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy.
Cannons JL; Lau P; Ghumman B; DeBenedette MA; Yagita H; Okumura K; Watts TH
J Immunol; 2001 Aug; 167(3):1313-24. PubMed ID: 11466348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
